Apple and Masimo's patent and trade secret dispute has intensified through lawsuits as Apple defends its innovations and ...

Masimo Corp. ( (MASI) ) has released its Q3 earnings. Here is a breakdown of the information Masimo Corp. presented to its investors. Masimo ...

Apple and Masimo are back in a California court this week for a bench trial that will see Masimo arguing that Apple illegally poached its employees and stole trade secrets when developing the ...

Wells Fargo analyst Vik Chopra has assigned their bullish stance on MASI stock, giving a Buy rating yesterday. Vik Chopra has given his Buy ...

Masimo's non-GAAP EPS of $0.98 topped internal guidance. Healthcare revenue surged by 11.5% year over year to $343.3 million. Litigation with Apple heighten financial uncertainties for the company ...

On Wednesday, Piper Sandler maintained an Overweight rating on shares of Masimo Corp. (NASDAQ:{{16565|MAMASI) and increased the price target to $180 from $165. The adjustment follows Masimo's ...

Masimo (MASI) reported $504.6 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 5.4%. EPS of $0.98 for the same period compares to $0.63 a year ago.

Masimo MASI is set to give its latest quarterly earnings report on Tuesday, 2024-11-05. Here's what investors need to know before the announcement. Analysts estimate that Masimo will report an ...

Unrecognized Contract Revenues: $1.65 billion as of the end of Q3. Masimo Corp (NASDAQ:MASI) reported healthcare revenues of $343 million for the third quarter, representing a 12% growth compared ...

Masimo, SET, Signal Extraction Technology, Improving Patient Outcome and Reducing Cost of Care... by Taking Noninvasive Monitoring to New Sites and Applications, rainbow, SpHb, SpOC, SpCO ...